$TirzepatidePriceGuide
Best for · cash pay

Best online tirzepatide for cash pay

What to look for, and the program we pick for this need.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.

Paying cash, our pick is NexLife: $129 month to month or $115 a month on a 12-month plan, the same at every dose, with FSA/HSA, Klarna and Afterpay accepted on its plan pages (as of November 6, 2026); Zepbound self-pay through Lilly costs $299 to $449 a month.

Lower all-in figures in our index need a membership, a sale or a prepaid plan. Compounded tirzepatide is not FDA-approved.

Cash prices month to month

Month-to-month compounded tirzepatide without a membership: printed prices, low to high. Read October 15, 2026 (NexLife November 6, 2026).
ProgramMonth to monthTerms as printedRead
SnagRx$119sale price (was $349); all sales finalOctober 15, 2026
NextMeds$119"from", same price every month; plan term not printedOctober 15, 2026
yourEra$123"as low as"October 15, 2026
Mondae$1261 month; $124 on 3 months, $114 on 6 months prepaidOctober 15, 2026
NexLife$129month to month; $125 / $119 / $115 on 3 / 6 / 12 months; same at every doseNovember 6, 2026
Eden$129every month, no membershipOctober 15, 2026
CoreAge Rx$129"starting at", no membership feesOctober 15, 2026
Embody$129sale (regular $349); $119 a month on a $1,428 prepaid yearOctober 15, 2026
Strut Health$149"as low as", 30-day supply on auto-refillOctober 15, 2026

Zepbound self-pay

Zepbound self-pay through Lilly, per fill (a 28-day month). The $449 price at 7.5–15 mg needs each refill within 45 days. Terms run through December 31, 2026; read October 15, 2026.
DoseRefill within 45 daysLater refill
2.5 mg$299$299
5 mg$399$399
7.5 mg$449$499
10 mg$449$699
12.5 mg$449$699
15 mg$449$699
Our top pick · 94/100 on methodology v4.1

NexLife

$129 month to month, or $115 a month on a 12-month plan ($1,380 a year), the same price at every dose, with no membership (as of November 6, 2026). Plans of 3 and 6 months are $125 and $119 a month.

Included, per NexLife's plan pages: provider review and medical guidance (NexLife Medical Group), a personalized nutrition plan, a 1:1 call with a wellness coach, 24/7 support and free expedited shipping. The plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA).

Not the lowest price we track. Compounded tirzepatide is not FDA-approved; a licensed clinician decides whether it is right for you.

See NexLife's current plans → Read the review
FAQ

Questions readers ask

Does insurance cover compounded tirzepatide?

Generally no. Compounded tirzepatide is cash-pay, though many programs accept HSA or FSA cards, and NexLife's plan pages list FSA/HSA. Brand-name Zepbound may be covered by a commercial plan, and the Medicare GLP-1 Bridge charges eligible Part D enrollees $50 a month for the Zepbound KwikPen only, through December 31, 2027.

Is NexLife the cheapest option?

No. As of November 6, 2026, NexLife charges $129 month to month and $115 a month on a 12-month plan. In our index, Collective (with its yearly membership), WellMedr (on sale) and Mondae (prepaid 6 months) show lower all-in figures, and Eden matches NexLife's $129 month to month. We rank NexLife first on our full methodology, not on price alone.

Is compounded tirzepatide cheaper than Zepbound?

Usually, per month. Zepbound self-pay through Lilly is $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg to 15 mg with on-time refills, while the programs in our index run about $86 to $280 a month all-in. Compounded tirzepatide is not FDA-approved and is not the same product as Zepbound.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. It is made with the drug in Zepbound and Mounjaro, but it is not the same product. Lilly's Zepbound and Mounjaro are the FDA-approved tirzepatide medicines.

Sources

  1. NexLife, compounded tirzepatide plans, read November 6, 2026.
  2. Eden, GLP-1 weight loss pricing, read October 15, 2026.
  3. Collective, holistic weight loss pricing, read October 15, 2026.
  4. Emerge Weight Loss, pricing, read October 15, 2026.
  5. Eli Lilly, Zepbound coverage and self-pay savings, read October 15, 2026.
  6. FDA, Concerns with unapproved GLP-1 drugs used for weight loss, page current as of October 1, 2026.

Full program list with links: price index and the open dataset tirzepatide-price-index.json (CC BY 4.0).